FREMONT, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Seeking to expand the knowledge base surrounding spectral flow cytometry, Cytek Biosciences, Inc. (CTKB) (Nasdaq: CTKB), a leading cell analysis ...

As the fields of flow cytometry and spatial biology advance, researchers are uncovering exciting applications for the expanding data from their samples. Innovative reagents, fluidic and optical ...

After five decades of use, flow cytometry is entrenched in biomedical science. Besides enabling the quick processing of cells in suspension, flow cytometry provides quantitative results across ...

FREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- With cancer research and diagnostics driving the need for deeper, faster cellular insights, spectral flow cytometry leader Cytek Biosciences, Inc.

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a new era of and accessibility. This ...

KANSAS CITY, Kan., April 14, 2026--(BUSINESS WIRE)--KCAS Bio, a global provider of harmonized spectral flow cytometry, today announced ongoing developments in its service offering – focused on ...

As translational immunology moves toward increasingly complex and clinically driven questions, flow cytometry must deliver both speed and analytical depth. This presentation highlights how the ...

This article is based on a poster originally authored by S. Sanderson, R. Cuthbert, M. Blundell, and T. Long, which was presented at ELRIG Drug Discovery 2024 in affiliation with Bio-Rad Laboratories.

A 24-parameter spectral flow cytometry panel was developed to monitor immune receptor expression in MS patients, aiding personalized treatment approaches. The panel detects 12 treatment-associated ...

Spectral flow cytometry collects the full emission spectrum of a fluorochrome, enabling multicolor panels with more parameters than conventional flow cytometry. As scientists discover the subtle ...

Not all patients respond well to chimeric antigen receptor (CAR) T cell therapies, which reprogram a patient’s own immune cells to recognize and attack cancer. A way to optimize these treatments is to ...

The MarketWatch News Department was not involved in the creation of this content. CHICAGO, June 11, 2024 /PRNewswire/ -- The global flow cytometry market, valued at $5.1 billion in 2024, is primed for ...